KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Goodwill (2016 - 2025)

Historic Goodwill for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $24.0 billion.

  • Abbott Laboratories' Goodwill rose 126.58% to $24.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $24.0 billion, marking a year-over-year increase of 126.58%. This contributed to the annual value of $23.1 billion for FY2024, which is 249.79% down from last year.
  • According to the latest figures from Q3 2025, Abbott Laboratories' Goodwill is $24.0 billion, which was up 126.58% from $24.0 billion recorded in Q2 2025.
  • Abbott Laboratories' 5-year Goodwill high stood at $24.0 billion for Q2 2025, and its period low was $22.3 billion during Q3 2022.
  • For the 5-year period, Abbott Laboratories' Goodwill averaged around $23.3 billion, with its median value being $23.3 billion (2021).
  • Its Goodwill has fluctuated over the past 5 years, first plummeted by 429.18% in 2022, then skyrocketed by 448.43% in 2023.
  • Over the past 5 years, Abbott Laboratories' Goodwill (Quarter) stood at $23.2 billion in 2021, then fell by 1.86% to $22.8 billion in 2022, then grew by 3.95% to $23.7 billion in 2023, then fell by 2.5% to $23.1 billion in 2024, then grew by 3.86% to $24.0 billion in 2025.
  • Its last three reported values are $24.0 billion in Q3 2025, $24.0 billion for Q2 2025, and $23.4 billion during Q1 2025.